CMV-related thrombocytopenia treated with foscarnet: A case series and review of the literature

References

• Carter RL. Platelet levels in infectious mononucleosis. Blood 1965; 25: 817–821
   PubMed Web of Science ®Google Scholar
• Ibarra H, Zapata C, Inostroza J, Mezzano S, Riedemann S. Immune thrombocytopenic purpura associated with hepatitis a. Blut 1986; 52: 371–375
   PubMedGoogle Scholar
• Korman SH. Thrombocytopenic purpura during the incubation of hepatitis b. Acta Paediatr Scand 1991; 80: 975–976
   PubMed Web of Science ®Google Scholar
• Pawlotsky JM, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D, Bierling P. Hepatitis c virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23: 635–639
   PubMed Web of Science ®Google Scholar
• Morse EE, Zinkham WH, Jackson DP. Thrombocytopenic purpura following rubella infection in children and adults. Arch Intern Med 1966; 117: 573–579
   PubMedGoogle Scholar
• Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997; 81: 449–470
   PubMed Web of Science ®Google Scholar
• Chanarin I, Walford DM. Thrombocytopenic purpura in cytomegalovirus mononucleosis. Lancet 1973; 2: 238–239
   PubMed Web of Science ®Google Scholar
• DiMaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol 2009; 146: 104–112
   PubMed Web of Science ®Google Scholar
• Fiala M, Kattlove H. Cytomegalovirus mononucleosis with severe thrombocytopenia. Ann Intern Med 1973; 79: 450–451
   PubMed Web of Science ®Google Scholar
• Harris AI, Meyer RJ, Brody EA. Cytomegalovirus-induced thrombocytopenia and hemolysis in an adult. Ann Intern Med 1975; 83: 670–671
   PubMed Web of Science ®Google Scholar
• Sahud MA, Bachelor MM. Cytomegalovirus-induced thrombocytopenia. An unusual case report. Arch Intern Med 1978; 138: 1573–1575
   PubMedGoogle Scholar
• Shimm DS, Logue GL, Rosse WF. Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound igg in establishing cause. Arch Intern Med 1980; 140: 855–857
   PubMed Web of Science ®Google Scholar
• Wright JG. Severe thrombocytopenia secondary to asymptomatic cytomegalovirus infection in an immunocompetent host. J Clin Pathol 1992; 45: 1037–1038
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ, Kaplan B. Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult. West J Med 1993; 158: 525–526
   PubMedGoogle Scholar
• van Spronsen DJ, Breed WP. Cytomegalovirus-induced thrombocytopenia and haemolysis in an immunocompetent adult. Br J Haematol 1996; 92: 218–220
   PubMed Web of Science ®Google Scholar
• Arruda VR, Rossi CL, Nogueira E, Annicchino-Bizzacchi JM, Costa FF, Costa SC. Cytomegalovirus infection as cause of severe thrombocytopenia in a nonimmunosuppressed patient. Acta Haematol 1997; 98: 228–230
   PubMed Web of Science ®Google Scholar
• Miyahara M, Shimamoto Y, Yamada H, Shibata K, Matsuzaki M, Ono K. Cytomegalovirus-associated myelodysplasia and thrombocytopenia in an immunocompetent adult. Ann Hematol 1997; 74: 99–101
   PubMed Web of Science ®Google Scholar
• Gural A, Gillis S, Gafanovich A, Israel Z, Wolf D, Pomeranz S, Ben-Yehuda D. Massive intracranial bleeding requiring emergency splenectomy in a patient with cmv-associated thrombocytopenia. Haemostasis 1998; 28: 250–255
   PubMedGoogle Scholar
• Noguchi M, Aruga S, Kato A, Oshimi K. [Cytomegalovirus mononucleosis with severe thrombocytopenia]. Rinsho Ketsueki 2000; 41: 1171–1177
   PubMedGoogle Scholar
• Ichiche M, Fontaine C, Lacor P. Severe thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult. Eur J Intern Med 2003; 14: 56–59
   PubMedGoogle Scholar
• Alliot C, Barrios M. Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: A case report and review. Hematology 2005; 10: 277–279
   PubMed Web of Science ®Google Scholar
• Nomura K, Matsumoto Y, Kotoura Y, Shimizu D, Kamitsuji Y, Horiike S, Tamiwaki M. Thrombocytopenia due to cytomegalovirus infection in an immunocompetent adult. Hematology 2005; 10: 405–406
   PubMed Web of Science ®Google Scholar
• Levy AS, Bussel J. Immune thrombocytopenic purpura: Investigation of the role of cytomegalovirus infection. Br J Haematol 2004; 126: 622–623
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhao L, Mei H, Zhang SL, Huang ZH. Role of myeloid human cytomegalovirus infection in children's idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2007; 24: 179–188
   PubMed Web of Science ®Google Scholar
• Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser J, et al. Amg 531, a thrombopoiesis-stimulating protein, for chronic itp. N Engl J Med 2006; 355: 1672–1681
   PubMed Web of Science ®Google Scholar
• Xiao Y, Lin W, Liu Q, Jin R, Fei H. Direct infection of colony forming unit-megakaryocyte by human cytomegalovirus contributes the pathogenesis of idiopathic thrombocytopenic purpura. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 555–557
   PubMedGoogle Scholar
• Atzmony L, Grosfeld A, Saar N, Justo D. Inherited and acquired predispositions for thrombosis in immunocompetent patients with cytomegalovirus-associated thrombosis. Eur J Intern Med 2010; 21: 2–5
   PubMed Web of Science ®Google Scholar
• Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: Role of antiphospholipid antibodies. J Infect 2007; 54: e47–50
   Web of Science ®Google Scholar
• Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood 1986; 67: 203–206
   PubMed Web of Science ®Google Scholar
• Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time pcr. J Clin Microbiol 2004; 42: 1142–1148
   PubMed Web of Science ®Google Scholar
• Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, et al. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis 2008; 46: 1455–1457
   PubMed Web of Science ®Google Scholar